Watson is here to cure cancer

December 5, 2016 News BioVox

The cooperation between Pfizer and IBM concerning Watson, an artificial intelligence system, was announced on the Forbes Healthcare Summit following a pilot project during the past year and a half.

Specifically, Watson will hunt for drugs that can be used in cancer immunotherapy. Watson is able to interpret loads of information, and therefore allows suggesting the best treatment much more quickly than humans can. Rapidly recognizing and associating anomalies is key in this process. Analyzing these large amounts of medical literature requires a massive amount of computing capacity.


Avatar photo

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is an independent publisher, providing its community with quality content and first-row access to interesting breakthroughs and trends in biotech, medtech, agtech, pharma, and more. We shine a spotlight on the latest news and innovations from both our partners and community.

All posts


* indicates required

Intuit Mailchimp